• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Acceptys

edit

Acceptys, Inc., a biotechnology company, engages in the development of human antibody therapies in cancer and infectious diseases. It offers anti-cancer and anti-viral human antibodies for lung, pancreatic, gastric, and/or colon cancers. The company was founded in 2002 and is based in Sparta, New Jersey. As of December 3, 2008, Acceptys, Inc. operates as a subsidiary of Patrys Limited.

Recent Milestones

edit

• 
  Acceptys was acquired by Patrys for $2.82M. (10/27/08)
  Posted 9/10/09 at 4:09am via biospace.com
• 
  Acceptys added Daniel Devine as CEO.
  Posted 9/10/09 at 4:01am
• 
  Acceptys added Tony Giordano as CSO.
  Posted 9/10/09 at 4:01am

Videos

Screenshots

edit

Sources

1. Patrys Limited to Acquire Assets of Acceptys, Inc. (biospace.com) [edit]